These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4099827)

  • 21. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tubercle; 1968 Mar; 49():Suppl:66-70. PubMed ID: 4173333
    [No Abstract]   [Full Text] [Related]  

  • 24. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotics, antiseptics and tubercle bacilli.
    McDonald PJ; Murray CJ; McDonald HM
    Med J Aust; 1974 Jul; 2(2):41-5. PubMed ID: 4212945
    [No Abstract]   [Full Text] [Related]  

  • 26. Addendum on serum levels.
    Begg KJ
    Tubercle; 1967 Jun; 48(2):149-50. PubMed ID: 6048657
    [No Abstract]   [Full Text] [Related]  

  • 27. Initial resistance of Mycobacterium tuberculosis in Northern Nigeria.
    Fawcett IW; Watkins BJ
    Tubercle; 1976 Mar; 57(1):71-3. PubMed ID: 59991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 29. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 31. Microbiology of cutaneous tuberculosis.
    Sharma RC; Singh R; Bhatia VN
    Tubercle; 1975 Dec; 56(4):324-8. PubMed ID: 59443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistant tubercle bacilli.
    Lancet; 1972 Aug; 2(7774):412-3. PubMed ID: 4115230
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 34. [Paper disk methods for determination of the drug sensitivity of Mycobacterium tuberculosis to the 2d order preparations. II].
    Afanas'eva IuP; Dorozhkova IR
    Lab Delo; 1969; 5():296-8. PubMed ID: 4185263
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL; Johnson PM; Boytar-Papirnyik V; Wilber J
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract]   [Full Text] [Related]  

  • 36. MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES.
    WOLINSKY E
    Med Clin North Am; 1963 Sep; 47():1271-83. PubMed ID: 14062093
    [No Abstract]   [Full Text] [Related]  

  • 37. [Present state of resistance to antibiotics by tuberculous bacilli in Africa (author's transl)].
    Rey JL; Villon A; Menard M; Le Mao G; Albert JP
    Med Trop (Mars); 1979; 39(2):149-54. PubMed ID: 91079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance and speed of growth of M. tuberculosis. 2. Vulnerable and invulnerable types of resistance.
    Zykov MP; Donets JI; Poti SJ
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):40-56. PubMed ID: 4113512
    [No Abstract]   [Full Text] [Related]  

  • 39. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.